(Q53090697)

English

Evaluation of the effect of ruxolitinib on cardiac repolarization: A thorough QT study.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

Evaluation of the effect of ruxolitinib on cardiac repolarization: A thorough QT study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

1 reference

based on heuristic

inferred from title

author name string

Naresh Punwani

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

Swamy Yeleswaram

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

Xuejun Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

Jill Bowman

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

Maxim Soloviev

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

William Williams

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

publication date

6 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

Clinical pharmacology in drug development

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

207-214

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

21 January 2018

The pharmacokinetics, pharmacodynamics, and safety of orally dosed INCB018424 phosphate in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

21 January 2018

Metabolism, excretion, and pharmacokinetics of [14C]INCB018424, a selective Janus tyrosine kinase 1/2 inhibitor, in humans

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

21 January 2018

Drug-induced torsades de pointes and implications for drug development.

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

21 January 2018

Drug-induced prolongation of the QT interval

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

21 January 2018

The Duration of Systole in an Electrocardiogram in Normal Humans and in Patients with Heart Disease*

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

21 January 2018

Population pharmacokinetic analysis of orally-administered ruxolitinib (INCB018424 Phosphate) in patients with primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) or post-essential thrombocythemia myelofibrosis (PET MF).

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

21 January 2018

The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac repolarization and the safety of new drugs defined by electrocardiography

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.90

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CPDD.90

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/27128611

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53090697&oldid=1516987691"